Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.
Zannad F, Stough WG, Lipicky RJ, Tamargo J, Bakris GL, Borer JS, Alonso García Mde L, Hadjadj S, Koenig W, Kupfer S, McCullough PA, Mosenzon O, Pocock S, Scheen AJ, Sourij H, Van der Schueren B, Stahre C, White WB, Calvo G. Zannad F, et al. Among authors: koenig w. Eur Heart J Cardiovasc Pharmacother. 2016 Jul;2(3):200-5. doi: 10.1093/ehjcvp/pvw007. Epub 2016 Apr 3. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27418973 Free PMC article. Review.
Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.
Zannad F, De Backer G, Graham I, Lorenz M, Mancia G, Morrow DA, Reiner Z, Koenig W, Dallongeville J, Macfadyen RJ, Ruilope LM, Wilhelmsen L; ESC Working Group on CardioVascular Pharmacology and Drug Therapy. Zannad F, et al. Among authors: koenig w. Fundam Clin Pharmacol. 2012 Apr;26(2):163-74. doi: 10.1111/j.1472-8206.2011.01023.x. Epub 2012 Jan 5. Fundam Clin Pharmacol. 2012. PMID: 22220636 Review.
Risk-guided therapy: a first step to personalized medicine.
Zannad F, Koenig W. Zannad F, et al. Among authors: koenig w. Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):5-6. doi: 10.1177/2047487312448991. Eur J Prev Cardiol. 2012. PMID: 22801063 No abstract available.
Conclusion.
Koenig W, Zannad F. Koenig W, et al. Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):54-5. doi: 10.1177/2047487312448992. Eur J Prev Cardiol. 2012. PMID: 22801070 No abstract available.
Prevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy.
Zannad F, Dallongeville J, Macfadyen RJ, Ruilope LM, Wilhelmsen L, De Backer G, Graham I, Lorenz M, Mancia G, Morrow DA, Reiner Z, Koenig W; ESC Working Group on CardioVascular Pharmacology and Drug Therapy. Zannad F, et al. Among authors: koenig w. Eur J Prev Cardiol. 2012 Dec;19(6):1454-64. doi: 10.1177/1741826711424873. Eur J Prev Cardiol. 2012. PMID: 23310961 Free PMC article.
Atherosclerosis: Recent trials, new targets and future directions.
Ladeiras-Lopes R, Agewall S, Tawakol A, Staels B, Stein E, Mentz RJ, Leite-Moreira A, Zannad F, Koenig W. Ladeiras-Lopes R, et al. Among authors: koenig w. Int J Cardiol. 2015 Aug 1;192:72-81. doi: 10.1016/j.ijcard.2015.05.013. Epub 2015 May 8. Int J Cardiol. 2015. PMID: 26002254 Review.
Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.
Zewinger S, Drechsler C, Kleber ME, Dressel A, Riffel J, Triem S, Lehmann M, Kopecky C, Säemann MD, Lepper PM, Silbernagel G, Scharnagl H, Ritsch A, Thorand B, de las Heras Gala T, Wagenpfeil S, Koenig W, Peters A, Laufs U, Wanner C, Fliser D, Speer T, März W. Zewinger S, et al. Among authors: koenig w. Eur Heart J. 2015 Nov 14;36(43):3007-16. doi: 10.1093/eurheartj/ehv352. Epub 2015 Aug 6. Eur Heart J. 2015. PMID: 26248570 Free article. Clinical Trial.
Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium.
Blankenberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, Jørgensen T, Thorand B, Peters A, Nauck M, Petersmann A, Vartiainen E, Veronesi G, Brambilla P, Costanzo S, Iacoviello L, Linden G, Yarnell J, Patterson CC, Everett BM, Ridker PM, Kontto J, Schnabel RB, Koenig W, Kee F, Zeller T, Kuulasmaa K; BiomarCaRE Investigators. Blankenberg S, et al. Among authors: koenig w. Eur Heart J. 2016 Aug 7;37(30):2428-37. doi: 10.1093/eurheartj/ehw172. Epub 2016 May 12. Eur Heart J. 2016. PMID: 27174290 Free PMC article.
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, Petrakis I, Dressel A, Lepper PM, Scharnagl H, Ritsch A, Thorand B, Heier M, Meisinger C, de Las Heras Gala T, Koenig W, Wagenpfeil S, Schwedhelm E, Böger RH, Laufs U, von Eckardstein A, Landmesser U, Lüscher TF, Fliser D, März W, Meinitzer A, Speer T. Zewinger S, et al. Among authors: koenig w. Eur Heart J. 2017 May 21;38(20):1597-1607. doi: 10.1093/eurheartj/ehx118. Eur Heart J. 2017. PMID: 28379378
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium.
Waldeyer C, Makarova N, Zeller T, Schnabel RB, Brunner FJ, Jørgensen T, Linneberg A, Niiranen T, Salomaa V, Jousilahti P, Yarnell J, Ferrario MM, Veronesi G, Brambilla P, Signorini SG, Iacoviello L, Costanzo S, Giampaoli S, Palmieri L, Meisinger C, Thorand B, Kee F, Koenig W, Ojeda F, Kontto J, Landmesser U, Kuulasmaa K, Blankenberg S. Waldeyer C, et al. Among authors: koenig w. Eur Heart J. 2017 Aug 21;38(32):2490-2498. doi: 10.1093/eurheartj/ehx166. Eur Heart J. 2017. PMID: 28449027 Free PMC article.
1,113 results